Thanks to The Lutrinae, the student-run newspaper covering California State University, Monterey Bay, for posting their article, “Six tips from the Students for Sensible Drug Policy to stay safe during Halloween.“ “While college students may be past their candy-collecting days, unfamiliar substances, chaotic environments and inexperience mean #Halloween can still be as risky as any horror story according to the
Community matters at SSDP, and that is why we are hosting monthly “SSDP Hangouts” for the SSDP family to get together to share upcoming projects, seek advice, and meet like-minded leaders. What to expect at a SSDP virtual hangout: Join us on zoom on November 3 at 6:00 PM ET for our next SSDP Hangout. Bring your ideas, a helpful
Two years ago today, SSDP and Last Prisoner Project joined forces to mobilize a rally in Washington D.C. for cannabis justice. Our goal then (and now) is to keep reminding the President of his campaign promise to release cannabis prisoners and provide them with retroactive relief. While this administration has made progress, President Biden has yet to release a single federal
We are grateful to Psychedelics Today for educating the community about the importance of DOI & DOC. “I have many colleagues who work with these compounds who will testify in the upcoming hearing, and that is only a subset of the research community,” said Elijah Ullman, Chair of SSDP’s Science Policy Council who has been interested in science policy since
In a significant development for psychedelics research, a Drug Enforcement Administration (DEA) administrative law judge has rejected the agency’s request to block key witnesses and evidence in an upcoming hearing. The case, set for November, challenges the DEA’s proposed ban on two psychedelic compounds, DOI and DOC, which are used in research. Thank you to Benzinga for sharing this important the DOI and DOC hearing news.
SSDP is proud to serve as a community partner for MAPS Psychedelic Science, taking place June 16-20, 2025 at the Colorado Convention Center in Denver. In 2023, Psychedelic Science hosted over 12,000 guests and was the largest psychedelic gathering in the world with classes and workshops, 10 educational stages, expo hall, and Deep Space, an immersive and interactive art experience.
“Science prevails!” SSDP Executive Director Kat Murti told Marijuana Moment on Monday. “The DEA is trying to force medical research into the dark ages by criminalizing DOI and DOC—essential research chemicals in pre-clinical psychiatry and neurobiology whose status as unscheduled compounds has made them de facto tools for researchers studying serotonin receptors.” “SSDP is proud to have brought together the
Published on October 7, 2024 in Investors Hangout by Owen Jenkins. The Drug Enforcement Administration (DEA) has caused quite a stir by denying testimony from important witnesses just before scheduled hearings on the potential classification of two psychedelic compounds, 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC). This decision has led to significant backlash from advocates, most notably the Students for Sensible Drug Policy
Coverage on October 7, 2024 in Benzinga by Juan Spínelli. “What is the DEA so scared of that these leading scientists must be muzzled?” asked Robert Rush, a Denver-based attorney representing SSDP. He criticized the agency for attempting to block testimony from some of the world’s foremost experts in neuroscience and pharmacology. Read more in Benzinga here.
We are grateful to Debra Borchardt from Green Market Report for her coverage on the DOI/DOC hearings published on October 4, 2024. “What is the DEA so scared of that these leading scientists must be muzzled?” said Robert Rush, a Denver-based attorney who is working hand-in-hand with SSDP to keep research using DOI and DOC legal. “By trying to silence
Special thanks to Jack Gorsline from Filter Magazine for a deeper look into the DEA’s response to our expert witnesses for the DOI and DOC hearing. Published on October 4, 2024. “We have assembled a world-class international group of behavioral and molecular pharmacologists, chemists, neuroscientists, and a former Government Advisor on psychoactive drugs,” added SSDP’s Elijah Ullman, who is himself pursuing
DOI and DOC’s current status as unscheduled compounds has made them de facto tools for researchers studying serotonin receptors. They have featured in more than 900 research articles and show promise for pain management, combatting anxiety and depression, and preventing overdose. Scheduling DOI and DOC would create serious impediments to potentially life-saving research, and yet SSDP is the only drug
Contact:Gina Giorgio Director of Strategy and DevelopmentStudents for Sensible Drug Policygina@ssdp.org DEA SILENCES SCIENTISTS; STUDENT GROUP PUSHES BACK AGAIN Since 2022, Students for Sensible Drug Policy (SSDP) Has Led the Fight to Prevent the DEA From Scheduling DOI and DOC, Which Would Create Serious Impediments to Potentially Life-Saving Research [Washington D.C., October 3, 2024] — Students for Sensible Drug Policy (SSDP)—a
SSDP was mentioned in The Assembly’s article discussing how North Carolina has been part of a national movement to broaden the use of MDMA to treat post-traumatic stress disorder and quoted SSDP’s Gina Giorgio. Last year, the Health House Standing Committee of the N.C. General Assembly approved the Breakthrough Therapies Research and Advisory Act unanimously, which would allocate $5.4 million to support
Contact:Gina Giorgio Director of Strategy and DevelopmentStudents for Sensible Drug Policygina@ssdp.org DEA SCHEDULES FIRST-EVER TWO WEEK PUBLIC HEARING ON PSYCHEDELICS IN ONGOING STUDENT-LED EFFORT TO PREVENT THE WRONGFUL SCHEDULING OF VITAL RESEARCH CHEMICALS WITH PROMISING MEDICAL POTENTIAL Since 2022, Students for Sensible Drug Policy (SSDP) Has Led the Fight to Prevent the DEA From Scheduling DOI and DOC, Which Would Create
Contact:Kat MurtiExecutive DirectorStudents for Sensible Drug Policykat@ssdp.org STUDENT-LED NONPROFIT FIGHTS THE DEA IN COURT IN EFFORT TO PRESERVE ACCESS TO VITAL RESEARCH CHEMICALS WITH PROMISING MEDICAL POTENTIAL Students for Sensible Drug Policy (SSDP) is the Only Drug Policy Organization Actively Working to Prevent the DEA From Scheduling DOI and DOC, Which Would Create Serious Impediments to Potentially Life-Saving Research [Washington
SSDP is grateful for the support of our Round Up program by Green Thumb Industries (GTI). Round Up presents patients and customers at RISE Dispensaries with the opportunity to round their purchases up to the nearest dollar in support of SSDP. To continue the momentum of the Company’s social impact initiatives, Green Thumb is introducing a matching component to its